Fact CheckerSign in

NCT06520709Completed

Kinesiophobia in Postmenopausal Osteoporosis

Kinesiophobia and Associated Factors in Postmenopausal Osteoporosis: A Controlled Study

Source: ClinicalTrials.gov · Last updated 25 Jul 2024

Brief summary (registry, in English)

This study aims to evaluate kinesiophobia levels in postmenopausal women with osteoporosis compared to a healthy control group and to explore the relationships between kinesiophobia and various psychosocial factors, including quality of life, fear of falling, and symptoms of depression and anxiety.

Status (registry)
Completed
Study type
Observational
Enrollment
60 (actual)
First submitted
20 Jul 2024
Start date
21 Jan 2024
Primary completion date
21 Feb 2024
Lead sponsor
Beylikduzu State Hospital
Diseases
Osteoporosis
NCT number
NCT06520709

What you commit to

  • Study type: Observational
  • Participants enrolled: 60
  • From 21 Jan 2024 to the primary completion date, 21 Feb 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Comorbid Conditions: Presence of other musculoskeletal, neurological, or psychiatric diseases that could influence kinesiophobia or pain.
  • Acute Conditions: Presence of acute painful conditions that might affect the results.
  • Medications: Use of medications or presence of diseases that could cause balance or functional disorders.

Other

  • Cognitive or Communication Difficulties: Any cognitive dysfunction or communication issues that might impair the participant's ability to engage with the study.

Who the study is looking for

  • Diagnosis: Participants must be diagnosed with postmenopausal osteoporosis and have been under follow-up for at least six months.
  • Age: Individuals must be 50 years or older.
  • Health Status: Participants must have excluded secondary causes of osteoporosis.

Age in the registry: 50 years to - · Sex: Female

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Beylikdüzü State Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.

Kinesiophobia in Postmenopausal Osteoporosis (NCT06520709) – Frontlight Research